Company Monitoring Page for Epizyme

latest headlines for company on cafepharma

Boehringer Ingelheim and Epizyme Ink Collaboration Deal With $15 Million Upfront and $280 Million in Biobucks
BioSpace
Thu, 11/15/18 - 10:46 am
Tags:
cancer, R&D, drug development, Boehringer Ingelheim, Epizyme
FDA gives Epizyme a green light on trial recruitment, but tazemetostat isn’t completely out of the woods yet
Endpoints
Mon, 09/24/18 - 09:45 am
Tags:
Epizyme, clinical trials, FDA, tazemetostat
Despite FDA hold, Epizyme’s tazemetostat posts positive interim data
Fierce Biotech
Fri, 06/15/18 - 09:53 pm
Tags:
Epizyme, tazemetostat, follicular lymphoma, FDA
FDA Pumps the Brakes on Epizyme’s Top Cancer Drug Tazemetostat
Xconomy
Mon, 04/23/18 - 10:44 pm
Tags:
clinical trials, FDA, Epizyme, tazemetostat
Why Epizyme Inc.'s Shares Skyrocketed Thursday
Motley Fool
Fri, 06/16/17 - 09:56 am
Tags:
Epizyme, tazemetost, follicular lymphoma
Top Presentations to Look for at ASCO
Yahoo/24-7 Wall St
Tue, 05/30/17 - 11:35 am
Tags:
ASCO 2017, Merck, AbbVie, Eli Lilly, Bluebird Bio, Epizyme, Juno Therapeutics, Kite, Merus
Epizyme: Why Is Big Pharma Interested In This Small Biotech?
Seeking Alpha
Thu, 05/4/17 - 07:40 pm
Tags:
Epizyme, Big Pharma
Epizyme Earns $6 Million Milestone Payment from GlaxoSmithKline for Initiation of Clinical Development with First-in-Class PRMT5 Inhibitor
Yahoo
Thu, 09/15/16 - 09:26 am
Tags:
Epizyme, GSK, GSK3326595, cancer, PRMT5 inhibitors
Epizyme reports 2Q loss
Yahoo/AP
Mon, 08/8/16 - 09:57 am
Tags:
Epizyme, earnings
Epizyme partners with Roche to test cancer drug combo
BioPharma Dive
Thu, 06/23/16 - 08:22 pm
Tags:
Epizyme, Roche, PDL-1 inhibitors, diffuse large B-cell lymphoma, Tecentriq, tazemetostat
Epizyme’s Cancer Drug Studies to Continue; Some Tumors Wiped Out
Bloomberg
Mon, 06/20/16 - 09:53 am
Tags:
Epizyme, cancer, tazemetostat, non-Hodgkin's lymphoma
Epizyme lays out plans to have its cancer drug approved as soon as 2018
Bizjournals.com
Thu, 03/10/16 - 10:51 am
Tags:
Epizyme, tazemetostat, solid tumors, non-Hodgkin's lymphoma
10 Biotechs Short Sellers Are Betting Against
Yahoo/Benzinga
Wed, 12/30/15 - 10:40 am
Tags:
biotech, Global Blood Therapeutics, Clovis Oncology, Epizyme, Bluebird Bio, Puma Biotechnology, Tokai, MannKind, Myriad Genetics, Orexigan, KaloBios
For Epizyme chief executive, the work is personal
Boston Globe, MA
Sun, 12/6/15 - 10:18 am
Tags:
Epizyme, non-Hodgkin’s lymphoma, Robert Bazemore
Epizyme Beats Out the Market With FDA Approval
Yahoo/24-7 Wall St
Mon, 08/24/15 - 05:00 pm
Tags:
FDA, Epizyme, tazemetostat, INI1-negative tumors, synovial sarcoma
Epizyme parts ways with its CEO ahead of big Phase II cancer bet
Fierce Biotech
Fri, 08/7/15 - 10:41 am
Tags:
Epizyme, Robert Gould, blood cancers
Epizyme reports 2Q loss
Yahoo/AP
Thu, 08/6/15 - 10:39 am
Tags:
earnings, Epizyme
Celgene recommits to Epizyme, adding $620M in cancer drug bonuses
Fierce Biotech
Thu, 07/9/15 - 09:56 pm
Tags:
Celgene, Epizyme
Glimpse of promising lymphoma responses spurs a sharp spike in Epizyme shares
Fierce Biotech
Tue, 06/23/15 - 10:23 am
Tags:
lymphoma, EPZ-6438, Epizyme
Epizyme reports 1Q loss
Yahoo/AP
Wed, 04/29/15 - 09:22 am
Tags:
earnings, Epizyme

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.